The Nørregaard Lab
2023-2026
Ameliorating fibrotic progression in human chronic kidney disease - Prostaglandin E2 receptors as therapeutic target
2,852,352 kr.
2023-2025
Prostaglandin receptors as therapeutic targets in human chronic kidney disease
1,500,000 kr.
2020-2025
Innovative delivery systems for gene-edited stem cell therapy to target renal fibrosis
Hallas-Møller Ascending Investigator; 10,000,000 kr.
2022-2027
Trimming the fat - targeting fatty liver disease to prevent chronic kidney failure
Lundbeck Foundation Fellowship; 10,000,000 kr.
Awarded to H.A.M. Mutsaers
2016-2021
Prostaglandin E2 receptors as therapeutic targets in CKD
1,961,218 kr.
Karen Elise Jensens Fond
2021-2024
Uremic Toxins: Drivers of Cardiovascular Disease 2,986,000 kr.
2016-2021
Can we target fibrosis to prevent renal function decline in CKD?
2,160,854 kr.
2019-2021
Human precision-cut kidney slices as animal-free screening tool for anti-fibrotic drug development
600,000 kr.
Karen Elise Jensens Fond
2018-2021
Fibrose hos børn med misdannelser i urinvejene 3,000,000 kr.